A Closer Look at RA Treatment: Treat-to-Target Using Shared Decision-Making
In this episode, Dr. Stanley Cohen, Dr. Sheetal Desai, and Dr. Eric Ruderman discuss how to translate information on JAK inhibitors and other treatments for your patient population in the clinic, covering practical tips on using: Treat-to-target approaches Disease activity measures Shared decision-making Decision aids Translating clinical trial evidence Also included are the experts’ answers to questions from clinicians like you. Stanley B. Cohen, MDClinical ProfessorDepartment of Internal MedicineUniversity of Texas Southwestern Medical SchoolCo-DirectorDivision of RheumatologyPresbyterian HospitalCo-Medical DirectorMetroplex Clinical Research CenterDallas, Texas Sheetal Desai, MD, MSEdChief of RheumatologyProgram DirectorUniversity of California, IrvineIrvine, California Eric M. Ruderman, MDProfessor, Associate ChiefDivision of RheumatologyNorthwestern University Feinberg School of MedicineClinical Practice DirectorNorthwestern Medical GroupChicago, Illinois Download the accompanying slides at:https://bit.ly/3gHDE3s See the interactive video at:https://bit.ly/3oCOtpV